Announcement on Resignation of Senior Management Members
Filed with SSE · · 1 page · Chinese
Zhejiang Starry Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Starry Pharmaceutical
- Report for Q3 2025
- Announcement on Release of Pledge of Controlling Shareholders' Shares
- Announcement on Implementation of Semi-annual Dividend Distribution for 2025
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Full Text of 2025 Semi-annual Report
Later from Zhejiang Starry Pharmaceutical
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Announcement on Obtaining Drug Registration Certificate by Wholly-owned Subsidiary
- Announcement on Returning Raised Funds Temporarily Used for Supplementing Current Capital to Special Account for Raised Funds
- Announcement on Closing Investment Projects Financed by Raised Funds, Adjusting Investment Scale, and Using Residual Raised Funds to Permanently Supplement Current Capital
- Announcement on Cancellation of Special Accounts for Raised Funds
Follow Zhejiang Starry Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Starry Pharmaceutical